ARS Pharmaceuticals, Inc. SPRY Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s change in inventories?
- ARS Pharmaceuticals, Inc. (SPRY) reported change in inventories of $294K in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
- ARS Pharmaceuticals, Inc.'s change in inventories decreased by 96.5% year-over-year, from $8.45M to $294K.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.